Header Logo

Connection

Melody Cobleigh to Administration, Oral

Back to Details
This is a "connection" page, showing publications Melody Cobleigh has written about Administration, Oral.
Melody Cobleigh
Connection Strength
0.019
Administration, Oral
  1. Phase II study of sunitinib malate, an oral multitargeted tyrosine kinase inhibitor, in patients with metastatic breast cancer previously treated with an anthracycline and a taxane. J Clin Oncol. 2008 Apr 10; 26(11):1810-6.
    View in: PubMed
    Score: 0.019
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.